NDC 63304-202-01 - Nortriptyline Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63304-202
- Requested NDC
- 63304-202-01
- Package NDCs from labels
- 63304-202-01
- Manufacturer
- Ranbaxy Laboratories Limited
- Effective date
- 2008-01-04
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Nortriptyline Hydrochloride - Ranbaxy Laboratories Limited | Ranbaxy Laboratories Limited | 2008-01-04 | HUMAN PRESCRIPTION DRUG LABELING |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2013-02-13 | Indexing - Billing Unit |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63304-202-01 | Nortriptyline Hydrochloride | 480 mL in 1 BOTTLE | SOLUTION | 480 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63304-202-01 | ML - Milliliter | 63304-202 | 15aaeefe-0d59-4cfe-8885-0d0debe80531 | 1 | 2013-02-13 |
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | PAI Holdings, LLC dba PAI Pharma | 3fcabf90-357a-4a06-b680-9572dc28bcfe | 2026-01-26 | Boxed warning, Warnings, Adverse reactions | 312036 |
| Nortriptyline Hydrochloride | NORTRIPTYLINE HYDROCHLORIDE | Advagen Pharma Ltd | bef9e24d-e730-4801-ab25-75e7d6bde225 | 2026-01-07 | Boxed warning, Warnings, Adverse reactions | 312036 |
| 7FADF3B9-4987-E587-E295-FB02952A3514 | ced93eb0-e8b6-44b8-9d2c-e2afa92500f7 | 2008-01-04 | Boxed warning, Warnings, Adverse reactions | 7FADF3B9-4987-E587-E295-FB02952A3514 ced93eb0-e8b6-44b8-9d2c-e2afa92500f7 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.